Finecure Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Finecure Pharma

DeciZen not available for IPO

10 Year X-Ray of Finecure Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
ROCE % 30%32.2%34.1%27.7%37.2%43%38.1%32.7%25.7%-
Value Creation
Index
1.11.31.41.01.72.11.71.30.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 152031.244.865.187.298.6115124124
Sales YoY Gr.-33.3%55.7%43.8%45.3%34%13.1%17.1%7.4%-
Adj EPS 1.92.53.33.55.78.810.710.610.310.5
YoY Gr.-30.4%33.3%4.8%62.9%55.9%20.7%-0.6%-2.7%-
BVPS (₹) 7.810.313.516.822.430.841.451.962.662.6
Adj Net
Profit
2.43.24.24.47.211.213.613.513.113
Cash Flow from Ops. 0002.97.611.71112.911.4-
Debt/CF from Ops. 0000.200.10.10.10.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA22.6%12.4%7.4%
Adj EPS NA24.3%5.3%-2.7%
BVPSNA30.1%26.7%20.7%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
Return on
Equity %
24.527.527.922.92933.329.522.71816.8
Op. Profit
Mgn %
22.520.817.712.514.416.818.717.516.2NAN
Net Profit
Mgn %
16.215.813.59.911.112.913.811.710.610.8
Debt to
Equity
0.10.10.1000000-
Working Cap
Days
015012311710496971071220
Cash Conv.
Cycle
069525244363728240

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Finecure Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 10.5 0
TTM Sales (₹ Cr.) 124 0
BVPS (₹.) 62.6 10
Reserves (₹ Cr.) 67 -
P/BV 0.00 0.00
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 12.7
Face Value (₹) 10
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 2,413 -0.62,270 0.32,455 5.22,404 5
Adj EPS (₹) 6.5 247.9 72.57.6 71.27 26.4
Op. Profit Mgn % 12.56 193 bps15.17 554 bps12.84 427 bps12.90 253 bps
Net Profit Mgn % 7.73 154 bps9.99 418 bps8.95 345 bps8.47 143 bps

Management X-Ray of Finecure Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Finecure Pharma

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Finecure Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Sales15.0320.0331.1844.8465.1387.2498.64115.46123.98
Operating Expenses 11.6415.8625.6639.2555.8472.6180.2295.25103.96
Manufacturing Costs0.370.580.971.121.422.171.391.741.76
Material Costs7.9411.0718.1230.2442.7957.356172.8779.18
Employee Cost 1.091.672.593.404.716.227.159.049.66
Other Costs 2.242.543.984.496.936.8710.6911.6013.36
Operating Profit 3.384.175.515.599.2914.6318.4120.2120.02
Operating Profit Margin (%) 22.5%20.8%17.7%12.5%14.3%16.8%18.7%17.5%16.1%
Other Income 0.380.540.730.920.691.040.521.370.61
Interest 0.070.040.070.060.100.100.190.210.16
Depreciation 0.580.710.650.890.550.951.061.321.57
Exceptional Items 0000000-0.390
Profit Before Tax 3.113.965.525.569.3314.6117.6819.6718.90
Tax 0.620.791.311.142.093.364.035.865.56
Profit After Tax 2.493.174.214.417.2411.2613.6513.8113.34
PAT Margin (%) 16.6%15.8%13.5%9.8%11.1%12.9%13.8%12.0%10.8%
Adjusted EPS (₹)2.02.53.33.55.78.910.710.910.5
Dividend Payout Ratio (%)0%0%3%4%2%1%1%12%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19

Equity and Liabilities

Shareholders Fund 9.9313.0917.1521.3828.4039.1852.6466.2579.59
Share Capital 1.271.271.271.271.271.271.2712.7112.71
Reserves 8.6611.8215.8820.1127.1337.9151.3753.5566.88
Minority Interest000000000
Debt0.671.101.440.670.260.550.930.781.06
Long Term Debt000.060.010.250.290.930.400.24
Short Term Debt0.671.101.380.660.010.2600.380.81
Trade Payables1.703.895.137.508.7312.819.5921.7121.29
Others Liabilities 1.221.271.892.404.435.386.566.234.66
Total Liabilities 13.5319.3625.6131.9541.8257.9269.7294.98106.60

Fixed Assets

Gross Block7.909.2411.5613.0814.6116.6223.3926.6745.61
Accumulated Depreciation1.902.623.464.354.915.876.938.249.72
Net Fixed Assets66.628.108.739.7010.7616.4618.4235.89
CWIP 0000.416.739.2215.6525.6316.67
Investments 0.160.161.551.833.014.564.125.445.69
Inventories3.634.866.299.1210.2311.4612.1416.2620.25
Trade Receivables2.463.664.866.798.4513.0212.7117.0615.77
Cash Equivalents 0.183.364.104.092.107.966.514.555.83
Others Assets1.100.700.710.981.590.942.147.626.49
Total Assets 13.5319.3625.6131.9541.8257.9269.7294.98106.60

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Cash Flow From Operating Activity 2.877.5911.7011.0112.8611.37
PBT 5.569.3314.6117.6819.6718.90
Adjustment 0.630.560.580.961.211.60
Changes in Working Capital -1.98-0.9-0.58-3.5-2.41-3.05
Tax Paid -1.34-1.40-2.91-4.13-5.61-6.08
Cash Flow From Investing Activity -1.89-8.81-5.81-12.45-14.27-10.21
Capex -1.70-7.89-4.42-13.19-13.26-10.08
Net Investments -0.28-1.19-1.55000
Others 0.080.270.160.74-1.01-0.13
Cash Flow From Financing Activity -0.98-0.77-0.040-0.550.12
Net Proceeds from Shares 000000
Net Proceeds from Borrowing -0.050.200.28000
Interest Paid -0.06-0.14-0.14-0.1900
Dividend Paid -0.15-0.16-0.19-0.16-0.190
Others -0.72-0.6700.35-0.360.12
Net Cash Flow 0-1.995.85-1.44-1.971.28
PARTICULARSMar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Ratios
ROE (%)25.0527.527.8122.9129.0833.3229.7323.2918.33
ROCE (%)30.0132.2334.1227.6637.1943.0238.0532.7325.74
Asset Turnover Ratio1.111.221.391.561.771.751.551.41.23
PAT to CFO Conversion(x)1.152.392.782.51.781.01000
Working Capital Days
Receivable Days605650474345484748
Inventory Days887765635445444554
Payable Days789291766969677899

Finecure Pharmaceuticals Ltd Stock News

No data found.

Finecure Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Finecure Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Finecure Pharma stood at ₹0.00.
The latest P/E ratio of Finecure Pharma as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Finecure Pharma as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Finecure Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Finecure Pharma is ₹124.0 ( Cr.) .

About Finecure Pharmaceuticals Ltd

No data to display
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on